Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

News

The French anti-doping agency says the UCI confirms it has jurisdiction to open discipline hearings on Armstrong.

Lance Armstrong's 20-minute shower last month may be getting him into more hot water. The French anti-doping agency, AFLD, said Thursday it may go ahead with disciplinary hearings against Armstrong for allegedly violating international anti-doping rules by leaving a French out-of-competition drug tester cooling his heels while Armstrong took a shower after a training ride. Armstrong has denied misbehaving during a test of his hair, urine and blood and notes that the tests came back negative for any kind of banned substance.

Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.

By Steve Frothingham

Lance Armstrong’s 20-minute shower last month may be getting him into more hot water.

The French anti-doping agency, AFLD, said Thursday it may go ahead with disciplinary hearings against Armstrong for allegedly violating international anti-doping rules by leaving a French out-of-competition drug tester cooling his heels while Armstrong took a shower after a training ride.

Armstrong has denied misbehaving during a test of his hair, urine and blood and notes that the tests came back negative for any kind of banned substance.

But the agency, in a statement released on its Web site Thursday, said Armstrong “did not respect the obligation to remain under the direct and permanent observation” of the tester, citing rules of the International Standard for Testing it said require an athlete to remain with the tester once he has been notified of the test. (Rule below)

The statement said the international cycling federation, UCI, has given it permission to open disciplinary procedures against Armstrong. UCI chief Pat McQuaid wrote to the French agency Wednesday, confirming that the French agency, not the UCI, has jurisdiction over any potential hearings and discipline, the AFLD said.

In a statement earlier this week, Armstrong said he was outraged by the allegations.

“I did not try to evade or delay the testing process that day. I had just returned from an all day training session, wasn’t sure who this French man at my home was, and as soon as the UCI confirmed that he was authorized to conduct the tests, I let him take all the samples he requested.”

Armstrong said he had returned to a rented house to find a man who said he was a tester waiting. While Armstrong’s team director Johan Bruyneel examined the man’s credentials and called the UCI to confirm his identity and jurisdiction, Armstrong took a shower.

The AFLD’s statement said the tester “repeatedly” warned Armstrong that he needed to remain under direct observation.


The rule cited by the AFLD
5.4 Requirements for notification of Athletes

5.4.1 When initial contact is made, the ADO, DCO or Chaperone, as applicable, shall ensure that the Athlete and/or a third party (if required in accordance with Clause 5.3.8) is informed:

a) That the Athlete is required to undergo a Sample collection;

b) Of the authority under which the Sample collection is to be conducted;

c) Of the type of Sample collection and any conditions that need to be adhered to prior to the Sample collection;

d) Of the Athlete’s rights, including the right to:

i. Have a representative and if available, an interpreter;

ii. Ask for additional information about the Sample collection process;

iii. Request a delay in reporting to the Doping Control Station for valid reasons; and

iv. Request modifications as provided for in Annex B – Modifications for Athletes with disabilities.

e) Of the Athlete’s responsibilities, including the requirement to:

i. Remain within direct observation of the DCO/Chaperone at all times from the point of notification by the DCO/Chaperone until the completion of the Sample collection procedure;
Rule 5.4.1, International Standard for Testing, January 2009